Are we really seeing the total costs of surgical site infections? A Spanish study
To identify overall costs generated by surgical site infections (SSI) patients, including indirect costs. A prospective study of case series of patients who have undergone major surgical treatment was undertaken. Patients who suffered SSI were compared with controls (nested case-control design). Centers for Disease Control and Prevention definitions were followed and SSI established. Overall costs and indirect related morbidity/mortality costs were estimated. The study was performed in a general, tertiary hospital (Valencia, Spain) for 4.5 years. Surgical site infections patients were 9.02% of the total people who underwent surgery. Their stays were prolonging by 14 days, and resources were used more intensely and for longer periods than in controls. Excess hospital costs were $10,232 per patient of which 37% corresponded to prolonged stays. Health costs only accounted for 10% of overall costs; $97,433 per patient including indirect social costs. Studies merely assessing excess costs due to prolonged stays of SSI patients do not reflect the entire scenario as they simply represent 35% of real hospital costs. A comprehensive appraisal shows that total healthcare expenditures represent a tenth of overall costs, which strengthens the claims that investment in preventing SSI would be highly cost-effective.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society - 15(2007), 4 vom: 15. Juli, Seite 474-81 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alfonso, Jose Luis [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.12.2007 Date Revised 10.03.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM171658116 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM171658116 | ||
| 003 | DE-627 | ||
| 005 | 20231223130134.0 | ||
| 007 | tu | ||
| 008 | 231223s2007 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0572.xml |
| 035 | |a (DE-627)NLM171658116 | ||
| 035 | |a (NLM)17650090 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alfonso, Jose Luis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Are we really seeing the total costs of surgical site infections? A Spanish study |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 14.12.2007 | ||
| 500 | |a Date Revised 10.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a To identify overall costs generated by surgical site infections (SSI) patients, including indirect costs. A prospective study of case series of patients who have undergone major surgical treatment was undertaken. Patients who suffered SSI were compared with controls (nested case-control design). Centers for Disease Control and Prevention definitions were followed and SSI established. Overall costs and indirect related morbidity/mortality costs were estimated. The study was performed in a general, tertiary hospital (Valencia, Spain) for 4.5 years. Surgical site infections patients were 9.02% of the total people who underwent surgery. Their stays were prolonging by 14 days, and resources were used more intensely and for longer periods than in controls. Excess hospital costs were $10,232 per patient of which 37% corresponded to prolonged stays. Health costs only accounted for 10% of overall costs; $97,433 per patient including indirect social costs. Studies merely assessing excess costs due to prolonged stays of SSI patients do not reflect the entire scenario as they simply represent 35% of real hospital costs. A comprehensive appraisal shows that total healthcare expenditures represent a tenth of overall costs, which strengthens the claims that investment in preventing SSI would be highly cost-effective | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Pereperez, Sergio Blasco |e verfasserin |4 aut | |
| 700 | 1 | |a Canoves, Jose Moreno |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez, Mercedes Melgar |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez, Isabel Martinez |e verfasserin |4 aut | |
| 700 | 1 | |a Martin-Moreno, Jose M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society |d 1993 |g 15(2007), 4 vom: 15. Juli, Seite 474-81 |w (DE-627)NLM092627307 |x 1524-475X |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2007 |g number:4 |g day:15 |g month:07 |g pages:474-81 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2007 |e 4 |b 15 |c 07 |h 474-81 | ||